Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Beatrice Deygas"'
Autor:
C Marc Samama, Pronomos Investigators, Patrick Mouret, Javier Martínez-Martín, Nadia Rosencher, Michel Cucherat, Daniel Duverger, Patrick Mismetti, Beatrice Deygas, Emilie Presles, Juan Llau, William Fisher, Philippe Girard, Silvy Laporte
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2020, 382 (20), pp.1916-1925. ⟨10.1056/NEJMoa1913808⟩
New England Journal of Medicine, Massachusetts Medical Society, 2020, 382 (20), pp.1916-1925. ⟨10.1056/NEJMoa1913808⟩
International audience; Background: Nonmajor orthopedic surgery of the lower limbs that results in transient reduced mobility places patients at risk for venous thromboembolism. Rivaroxaban may be noninferior to enoxaparin with regard to the preventi
Autor:
Patrick, Mismetti, Charles-Marc, Samama, Nadia, Rosencher, Claude, Vielpeau, Philippe, Nguyen, Beatrice, Deygas, Emilie, Presles, Silvy, Laporte, S, Ausset
Publikováno v:
Thrombosis and haemostasis. 107(6)
SummaryDespite the need for effective and safe thromboprophylactic drugs for patients with renal impairment, clinical trial data on anticoagulant agents are limited in this population. The study aim was to assess in the real-world setting the use of
Autor:
Denis Baylot, Paul Zufferey, Patrick Mismetti, Xavier Delavenne, Silvy Laporte, Philippe Nguyen, Michaela Fontenay, Pop-A-Rix Investigators, Beatrice Deygas, Jeanne-Yvonne Borg
Publikováno v:
Thrombosis and haemostasis. 104(2)
SummaryFondaparinux is a synthetic antithrombotic agent with specific anti-factor Xa activity. A population pharmacokinetic model of fondaparinux, based on data obtained in patients included in phase II/III trials, has been described. However, the va